Filter
2459
Filtered Results: 2459
Text search:
Trends
in
HIV
Prevalence
Featured
Recommendations
166
New Publications
754
Language
Document type
No document type
1680
Studies & Reports
414
Guidelines
165
Strategic & Response Plan
68
Manuals
54
Fact sheets
34
Training Material
19
Situation Updates
14
Infographics
8
Resource Platforms
3
Countries / Regions
India
127
Kenya
118
Ethiopia
83
Global
74
Nepal
69
Nigeria
68
Malawi
64
Rwanda
63
Tanzania
62
Uganda
62
Zambia
57
Western and Central Europe
55
South Africa
55
Liberia
48
Sierra Leone
47
Africa
46
Lesotho
43
Ghana
41
Zimbabwe
41
Bangladesh
39
Myanmar / Burma
39
Namibia
33
Asia
29
Eastern Europe
29
Latin America and the Carribbean
28
Ukraine
25
Mozambique
25
Indonesia
24
Senegal
22
Cambodia
21
South–East Asia Region
21
Philippines
20
Botswana
16
Burkina Faso
15
Haiti
13
Congo, Democratic Republic of
13
Eswatini/ Swaziland
12
Pakistan
10
Syria
9
Albania
9
Germany
9
East and Southern Africa
9
Russia
9
Cameroon
8
South Sudan
8
Tajikistan
7
Guinea
7
Venezuela
6
Middle East and North Africa
6
Eastern Europe and Central Asia
6
Moldova
6
Sudan
6
Somalia
6
Burundi
5
Brazil
5
North Macedonia
4
Afghanistan
4
Jordan
4
West and Central Africa
4
Vietnam
4
Georgia
4
Central African Republic
4
Colombia
3
Turkey
3
Peru
3
Armenia
3
Western Pacific Region
3
Papua New Guinea
3
Yemen
3
Thailand
2
Benin
2
Gambia
2
China
2
Iran
2
Laos
2
Estonia
2
Qatar
2
Jamaica
2
Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Lebanon
2
Sri Lanka
2
Egypt
2
Mali
2
Iraq
2
Madagascar
2
Timor Leste/ East Timor
1
Mexico
1
El Salvador
1
Serbia
1
Kazakhstan
1
Chile
1
Canada
1
Singapore
1
Niger
1
Bulgaria
1
USA
1
Saudi Arabia
1
Paraguay
1
North America
1
Gabon
1
Turkmenistan
1
France
1
Mauritius
1
United Kingdom
1
Portugal
1
Spain
1
Bolivia
1
Djibouti
1
Palestine
1
Poland
1
Honduras
1
Angola
1
Libya
1
Bhutan
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
1241
Clinical Guidelines
133
Women & Child Health
116
Public Health
96
Key Resources
61
Capacity Building
27
Pharmacy & Technologies
14
Toolboxes
HIV
379
TB
243
Mental Health
109
AMR
93
COVID-19
75
NTDs
54
Global Health Education
41
NCDs
38
Disability
33
Caregiver
30
Conflict
30
Planetary Health
27
Health Financing Toolbox
27
Refugee
24
Ebola & Marburg
19
Rapid Response
17
Pharmacy
13
Polio
10
Natural Hazards
9
Social Ethics
3
Cholera
2
Zika
2
South Sudan
1
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
BMC Infectious Diseases (2019) 19:832
Intestinal schistosomiasis is highly endemic in Tanzania and mass drug administration (MDA) using
praziquantel is the mainstay of the control program. However, the MDA program covers only school aged children
and does not include neither adult individuals nor...
Cancer in sub-Saharan Africa
recommended
Lancet Oncol 2022; 23: e251–312Published OnlineMay 9, 2022 https://doi.org/10.1016/S1470-2045(21)00720-8
In sub-Saharan Africa (SSA), urgent action is needed to curb a growing crisis in cancer incidence and mortality.
Without rapid interventions, data estimates show a major increase in cancer mo...
With this study, we estimated the burden of serious fungal infections for the general healthy population and for those at risk, including those infected with HIV, patients with asthma, as well as those under intensive care. We also highlight from studies in progress of high incidences of histoplasm...
USAID Senegal and Health in Africa (HIA) initiative of the World Bank Group engaged the Strengthening Health Outcomes through the Private Sector (SHOPS) project to conduct an assessment of the private health sector in Senegal. The assessment’s primary focus is family planning, and its secondary fo...
The intended purpose of this compendium is to provide program managers, organizations, and policy makers with a menu of indicators to better “know their HIV epidemic/know their response” from a gender perspective. The indicators in the compendium are all either part of existing indicators used i...
A healthcare worker manual. 2nd edition
The development of this National Manual for the Management of HIV-related Opportunistic Infections and Conditions for use by health care workers at the frontline of our fight against HIV/AIDS is intended to improve their understanding of the causes, preventio...
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ...
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also reviews the latest trends in the global supply of opi...
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS functions in the country, what actors are involved in this ...
This publication marks the 25th anniversary of the Beijing Declaration and Platform for Action. It is dedicated to the women leaders and allied community mobilizers who have devoted their lives to advancing the human rights and dignity of all people affected by the HIV epidemic, and to opposing soci...
Urogenital schistosomiasis is a common neglected tropical disease in many rural communities in African countries, with patches of infection in the Eastern Mediterranean Region. Globally, an estimated 239 million people are currently infected, with burden estimated at more than 3.5 million disability...
Masangane Case Study
The Vesper Society commissioned ARHAP to do research on the integrated Masangane HIV/AIDS programme affiliated with the Moravian Church in Eastern Cape, South Africa. Completed in 2006, this study aimed to understand the role of the religious health assets of the Masangane ART ...
Module 9
Strategic planning
July 2017
Module 9: Strategic planning. As WHO recommends offering PrEP to people at substantial HIV risk, this module offers public health guidance for policy-makers on how to prioritize services, in order to reach those who could benefit most from PrEP, and in wh...
Cancer is an emerging public health problem in sub-Saharan Africa due to population growth, ageing and westernisation of lifestyles. In this piece, we use data from Mozambique over a 50-year period to illustrate cancer epidemiological trends in low-income and middle-income countries to hypothesise ...
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and adolescents taking both dolutegravir and non-dolutegravir based regimens.
Results are used to inform A...
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid, ...
This regional advocacy strategy on HIV and AIDS, tuberculosis (TB) and sexually transmitted infetions (STIs) is intended for use by Southern African Development Community (SADC) Member States at a national level. This is an overall advocacy strategy highlighting the most important issues relating to...
Curr Opin Pharmacol . 2022 Apr;63:102203.doi: 10.1016/j.coph.2022.102203. Epub 2022 Feb 11.
The COVID-19 pandemic has widespread economic and social effects on Latin America (LA) and the Caribbean (CA). This region, which has a high prevalence of chronic diseases, has been one of the most affected...
This third regional report discusses gaps and challenges in reducing the harmful use of alcohol and how countries can reverse current trends in a cost-effective and expedited way.
